Bank Julius Baer & Co
HTGM

Bank Julius Baer & Co’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bank Julius Baer & Co’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,222
Closed -$132K – 864
2020
Q3 		$132K Buy
2,222
+2,083
+1,499% +$186K ﹤0.01% 553
2020
Q2 		$180K Sell
139
-1,280
-90% -$113K ﹤0.01% 485
2020
Q1 		$81K Buy
+1,419
New +$139K ﹤0.01% 509

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank Julius Baer & Co's HTGM Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2020, closing a stake of 2,222 shares — an estimated $132K sold.

Bank Julius Baer & Co first reported a position in HTGM in Q1 2020 and held it in 3 quarters. The position peaked at $180K in Q2 2020. 23 funds tracked by Wall St. Rank hold HTGM as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 2,222 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2020, an estimated $132K.
  • Bank Julius Baer & Co first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Bank Julius Baer & Co's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $180K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.